Currently, the treatment for DN is multiple, including antihyperglycemic drugs, lipid-lowering agents, renin–angiotensin–aldosterone system inhibitors (RAASi), and pharmacological alternatives for nephropathy [41, 42]. The gene discussed is REN; the disease is liver dysplastic nodule.